/Companies

QUICKSILVER BIOSCIENCES INC

New York, US · 1 known investors

Find your way into QUICKSILVER BIOSCIENCES INC

Sign up to see every warm intro you have to QUICKSILVER BIOSCIENCES INC

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the QUICKSILVER BIOSCIENCES INC team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Quicksilver Biosciences is developing a CMOS-integrated biosensor platform that uses proprietary sensing techniques to reach higher sensitivity in a portable, lower-cost form factor. The company is currently operating in stealth mode.

Investors · 1

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$447.8K
National Science FoundationPhase I2020$255.7K
National Science FoundationPhase I2019$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does QUICKSILVER BIOSCIENCES INC do?
Quicksilver Biosciences is developing a CMOS-integrated biosensor platform that uses proprietary sensing techniques to reach higher sensitivity in a portable, lower-cost form factor. The company is currently operating in stealth mode.
Who are QUICKSILVER BIOSCIENCES INC's investors?
QUICKSILVER BIOSCIENCES INC's investors include Kairos Venture Investments, Llc.
Where is QUICKSILVER BIOSCIENCES INC headquartered?
QUICKSILVER BIOSCIENCES INC is headquartered in New York, US.